Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall Street, and biotechnology. He is also a co-host of the weekly biotech podcast ...
MATAWAN, N.J.--(BUSINESS WIRE)-- Apimeds Pharmaceuticals US, Inc. (APUS) (“Apimeds”) today announced the expansion of its ai² Future Labs program by engaging graduate students from the University of ...
A catalyst for technology-based economic development in life sciences . In 1984, three of North Carolina’s largest ...
In the northwest corner of Sioux Falls, an 80-acre campus opened its first building this year dedicated entirely to expanding ...
Capital has become discerning. The inflated valuations of 2021 have given way to a more disciplined environment where ...
When Neal Piper’s son, Noah, rang the bell at UVA Children’s Hospital in December 2020, it signaled the end of grueling chemotherapy treatments connected to beeping monitors and intravenous tubes.
China, already gaining speed in biotechnology, is looking to further accelerate novel drug development by reducing the time regulators take to review clinical trials. In a draft policy posted (Chinese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback